Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

BACKGROUND: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Here, tofacitinib safety and efficacy data from a long-term extension study in Japanese patients are presented. METHODS: Study A3921041 was a multi-centre, open-label, long-term extension study that...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Arthritis Res Ther
Main Authors: Yamanaka, Hisashi, Tanaka, Yoshiya, Takeuchi, Tsutomu, Sugiyama, Naonobu, Yuasa, Hirotoshi, Toyoizumi, Shigeyuki, Morishima, Yosuke, Hirose, Tomohiro, Zwillich, Samuel
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4730592/
https://ncbi.nlm.nih.gov/pubmed/26818974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-0932-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki